Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Infarction
33%
All Cause Mortality
33%
Amiodarone
33%
Antiarrhythmic Agent
42%
Atrial Fibrillation
66%
Bleeding
6%
Cardiogenic Shock
33%
Clinical Study
33%
Congestive Heart Failure
6%
Heart Arrest
100%
Heart Arrhythmia
33%
Hospital Mortality
6%
Mineralocorticoid Antagonist
6%
Mortality Rate
6%
Out of Hospital Cardiac Arrest
50%
Pandemic
6%
Propafenone
23%
Recurrence Risk
16%
Recurrent Disease
33%
Retrospective Study
33%
Sudden Cardiac Death
100%
Survival Rate
33%
Nursing and Health Professions
Amiodarone
29%
Antiarrhythmic Agent
8%
Atrial Fibrillation
33%
Automated External Defibrillator
39%
Cardiopulmonary Resuscitation
6%
Cardioversion
33%
Defibrillation
39%
Defibrillator
33%
First Aid
6%
Health Practitioner
33%
Heart Arrest
23%
Heart Arrhythmia
11%
Heart Rhythm
6%
Influencing Factor
66%
Lung Embolism
33%
Medical Emergency
33%
Medical Practice
11%
Out of Hospital Cardiac Arrest
14%
Practice Guideline
33%
Propafenone
20%
Resuscitation
77%
Sinus Rhythm
29%
Sudden Cardiac Death
23%
Survival Rate
11%
Triage
42%
Medicine and Dentistry
Acute Coronary Syndrome
33%
Acute Heart Infarction
33%
All Cause Mortality
23%
Amiodarone
29%
Antiarrhythmic Agent
8%
Arm
9%
Atrial Fibrillation
66%
Cardiogenic Shock
33%
Cardioversion
33%
Clinical Pathway
33%
Congestive Heart Failure
8%
COVID-19
9%
Extracorporeal Membrane Oxygenation
33%
Hazard Ratio
9%
Heart Muscle Biopsy
33%
Infective Endocarditis
33%
Lead Extraction
8%
Myocardial Infarction
33%
Myocarditis
33%
Pathogen
8%
Patient-Reported Outcome
33%
Primary Percutaneous Coronary Intervention
12%
Propafenone
20%
Sinus Rhythm
29%
ST Elevation
6%
